Compare Recursion Pharmaceuticals Inc (RXRX) vs Under Armour Inc Class A (UA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Recursion Pharmaceuticals Inc vs Under Armour Inc Class A — how do they compare? Recursion Pharmaceuticals Inc trades at $3.07 (market cap $1.53B), while Under Armour Inc Class A trades at $7.18 (market cap $3.07B). The key difference: Under Armour Inc Class A is far larger — about 2× Recursion Pharmaceuticals Inc's market cap, and Under Armour Inc Class A is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| RXRX | UA | |
|---|---|---|
Market Cap | $1.53B | $3.07B |
Sector | Health | Consumer Cyclical |
52-Week High | $6.79 | $7.88 |
52-Week Low | $2.84 | $3.96 |
Enterprise Value | $946.50M | $4.70B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →About Under Armour Inc Class A
Under Armour is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Built on the 'technical' performance of synthetic fabrics, the company is currently undergoing a multi-year brand evolution centered on premium product innovation, operational rigor, and a renewed focus on its North American core under the guidance of founder Kevin Plank.
Read more on UA →
